Key facts
- Würzburg Dynamics’s last known valuation is $84.7M (Oct 2022).
- It has raised $30.6M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Guangzhou Jinkong Fund, 3E Bioventures Capital, Fosun Health Capital, Gongda VC, SSC Fund — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Würzburg Dynamics
- ·The full record, as it builds
Funding rounds
No funding rounds for Würzburg Dynamics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Würzburg Dynamics
Manufacturer of medical devices designed for surgery, soft tissue, and surgical robots. The company offers data analysis modules, patient-specific profiling tools, and clinical decision support systems with features such as genomic information processing, risk assessment algorithms, interoperability with hospital records, and visualization dashboards, enabling healthcare providers to enhance individualized treatment planning, improve diagnostic reliability, streamline medical workflows, and support evidence-based practices across diverse healthcare environments.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2019
- Employees
- 50
- Website
- wuerzburg-dynamics.com/
- Ownership
- Privately Held (backing)
Würzburg Dynamics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Würzburg Dynamics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Würzburg Dynamics in its N-PORT filings yet. We sweep new filings monthly.